Order Article Reprints

Bernard A, Danigo A, Mroué M, Rovini A, Richard L, Nizou A, Desmoulière A, Sturtz F, Demiot C, Bourthoumieu S. Blockade of Cholecystokinin Type 2 Receptors Prevents the Onset of Vincristine-Induced Neuropathy in Mice. Pharmaceutics. 2022; 14(12):2823. https://doi.org/10.3390/pharmaceutics14122823

Bernard, Amandine, Aurore Danigo, Mohamad Mroué, Amandine Rovini, Laurence Richard, Angélique Nizou, Alexis Desmoulière, Franck Sturtz, Claire Demiot, and Sylvie Bourthoumieu. 2022. "Blockade of Cholecystokinin Type 2 Receptors Prevents the Onset of Vincristine-Induced Neuropathy in Mice" Pharmaceutics 14, no. 12: 2823. https://doi.org/10.3390/pharmaceutics14122823

Bernard, A., Danigo, A., Mroué, M., Rovini, A., Richard, L., Nizou, A., Desmoulière, A., Sturtz, F., Demiot, C., & Bourthoumieu, S. (2022). Blockade of Cholecystokinin Type 2 Receptors Prevents the Onset of Vincristine-Induced Neuropathy in Mice. Pharmaceutics, 14(12), 2823. https://doi.org/10.3390/pharmaceutics14122823